Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Bipolar disorder is a mood disorder characterized by manic and depressive episodes.
• Calcium ion (Ca2+) signaling plays a crucial role in platelet function and neuronal activity.
• Lithium is a common mood-stabilizing medication used in bipolar disorder treatment.

Purpose of the Study:

• To investigate basal calcium-45 uptake into platelets.
• To examine the effect of lithium on calcium uptake in bipolar disorder patients and controls.
• To compare calcium uptake and lithium's effects between manic, depressed, and control groups.

Main Methods:

• Radiolabelled 45Ca2+ was used to measure basal uptake into platelets.
• The effect of 1 mM lithium on 45Ca2+ uptake was assessed.
• Platelet samples were analyzed from patients with bipolar disorder (manic and depressed phases) and healthy controls.

Main Results:

• Lithium significantly inhibited 45Ca2+ uptake into platelets across all groups.
• No significant differences were found in basal calcium uptake levels between the manic, depressed, and control groups.
• The inhibitory effect of lithium on calcium uptake did not differ significantly between the three groups.

Conclusions:

• Lithium's inhibitory effect on platelet calcium uptake is consistent across bipolar disorder phases and controls.
• Platelet calcium uptake may serve as a potential biomarker, although group differences were not observed in this study.
• Further research is warranted to elucidate the precise mechanisms of lithium's action on calcium signaling in bipolar disorder.